COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? Comment
10.1016/j.vaccine.2020.06.007
Saved in:
Main Authors: | Schaefer, G Owen, Tam, Clarence C, Savulescu, Julian, Voo, Teck Chuan |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Editorial |
Language: | English |
Published: |
ELSEVIER SCI LTD
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/228280 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
by: Kongsuphol, Patthara, et al.
Published: (2023) -
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
by: Le Bert, Nina, et al.
Published: (2022) -
Sentiments Regarding COVID-19 Vaccination among Graduate Students in Singapore
by: Lim, Lee Jin, et al.
Published: (2022) -
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
by: Lim, Xin Rong, et al.
Published: (2021) -
The rapid progress in COVID vaccine development and implementation
by: Barrett, Alan DT, et al.
Published: (2023)